Method and computer program for predicting neoantigen by using peptide sequence and hla allele sequence
AssigneeTheragen Bio Co., Ltd.
InventorsSeong-Eui HONG, Taesoon HWANG
Life of this patent
Estimating the term…
Loading patent…
AssigneeTheragen Bio Co., Ltd.
InventorsSeong-Eui HONG, Taesoon HWANG
Estimating the term…
The present disclosure provides a method for predicting a neoantigen by using a peptide sequence and an HLA allele sequence, the method comprising the steps of: receiving a peptide sequence and an HLA allele sequence both extracted from a target cancer tissue as an input; outputting a first prediction value that predicts immunogenicity of the peptide sequence, by acquiring T cell activity data from the peptide sequence and inputting the T cell activity data into an immunogenicity prediction model; outputting a second prediction value that predicts a binding affinity of the peptide sequence and the HLA allele sequence, by acquiring binding data from the HLA allele sequence and inputting the binding data into a binding prediction model; outputting a third prediction value that predicts immune tolerance of the target cancer tissue, by inputting the T cell activity data and the binding data to an immune tolerance prediction model; and generating neoantigen information of a target cell by using the T cell activity data and the first to third prediction value.
A method of predicting a neoantigen by using a peptide sequence and an HLA allele sequence, the method comprising the steps of:
Dependencies are inferred from the claim text.